Back to top
more

Inspire Medical Systems (INSP)

(Delayed Data from NYSE)

$158.59 USD

158.59
693,172

-1.01 (-0.63%)

Updated May 14, 2024 04:00 PM ET

After-Market: $158.60 +0.01 (0.01%) 6:20 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (140 out of 250)

Industry: Medical Info Systems

Better trading starts here.

Zacks News

Earnings Preview: Inspire Medical Systems (INSP) Q2 Earnings Expected to Decline

Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates

Inspire (INSP) delivered earnings and revenue surprises of -17.54% and 0.03%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Is a Surprise Coming for Inspire Medical (INSP) This Earnings Season?

Inspire Medical (INSP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Inspire Medical Systems (INSP) Stock Might be a Great Pick

Inspire Medical Systems (INSP) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Inspire Medical Systems (INSP) Reports Q4 Loss, Tops Revenue Estimates

Inspire (INSP) delivered earnings and revenue surprises of 9.52% and 12.62%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Why Inspire Medical Systems (INSP) Might Surprise This Earnings Season

Inspire (INSP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Inspire Medical Systems (INSP) Reports Q3 Loss, Tops Revenue Estimates

Inspire (INSP) delivered earnings and revenue surprises of 20.93% and 8.94%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Inspire Medical Systems (INSP) Q3 Earnings Expected to Decline

Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates

Inspire (INSP) delivered earnings and revenue surprises of 28.89% and 8.96%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Inspire Medical Systems (INSP) Q2 Earnings Expected to Decline

Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates

Inspire (INSP) delivered earnings and revenue surprises of 10.26% and 13.24%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Inspire Medical Systems (INSP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in the Cards for Match Group (MTCH) in Q4 Earnings?

Match Group (MTCH) is benefiting from increasing subscriber addition in the form of membership subscriptions. Tinder remains the key catalyst.

Sweta Killa headshot

U.S. IPO Market Stages Solid Comeback: ETFs to Bet On

The U.S. IPO market recorded the highest activity volume in the first six months of the year since 2014 and the fourth-busiest year-to-date period since 1995.